Top traditional therapy drugs by percent of total spending U.S. 2016

This statistic shows the leading traditional therapeutic drugs in the United States in 2016, based on percentage of total traditional spending. The drug Lantus (insulin glargine) for diabetes had the highest percent of total traditional spending, reaching 2.4 percent in that year.

Top 10 traditional therapy drugs in the U.S. by share of total traditional spending in 2016*

Characteristic	Percentage of total traditional spending
Lantus (insulin glargine)	2.4%
Humalog (insulin lispro injection)	1.7%
Metformin	1.6%
Vyvanse (lisdexamfetamine)	1.5%
Lialda (mesalamine)	1.3%
Januvia (sitagliptin)	1.3%
Esomeprazole magnesium	1.3%
Methylphenidate extended release	1.2%
Amphetamine/dextroamphetamine	1.2%
Lyrica (pregabalin)	1.2%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2017

More information

Region

United States

Survey time period

2016

Supplementary notes

* The statistic includes members with commercial insurance coverage. Members used Express Scripts for retail and home delivery pharmacy services; they used Accredo, the Express Scripts specialty pharmacy, for specialty drug prescriptions.

Citation formats